Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations
Although combination antiretroviral (ARV) therapy is highly effective in controlling the progression of HIV disease, drug resistance can be a major obstacle. Recent findings suggest that resistance can develop without ARV target gene mutations.
Guardado en:
Autores principales: | Yuta Hikichi, Rachel Van Duyne, Phuong Pham, Jennifer L. Groebner, Ann Wiegand, John W. Mellors, Mary F. Kearney, Eric O. Freed |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4bd72fa01324caca28f6cbce9932f14 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural mechanism of trimeric HIV-1 envelope glycoprotein activation.
por: Erin E H Tran, et al.
Publicado: (2012) -
Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein
por: Alessandro Piai, et al.
Publicado: (2020) -
Global site-specific N-glycosylation analysis of HIV envelope glycoprotein
por: Liwei Cao, et al.
Publicado: (2017) -
Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions
por: Anush Arakelyan, et al.
Publicado: (2017) -
Biochemical reconstitution of hemorrhagic-fever arenavirus envelope glycoprotein-mediated membrane fusion.
por: Celestine J Thomas, et al.
Publicado: (2012)